Skip to main content

Table 4 The GMFM-66 mean difference within-group (from baseline) and difference between groups

From: The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial

GMFM-66

T1

T2

T3

T4

Control group

0.92 [-2.39,4.23]

2.25 [-1.02,5.52]

1.56 [-1.29,4.41]

3.50 [0.52,6.48]

Experimental group

9.17 [5.28,13.06]

9.24 [5.84,12.65]

11.24 [6.48,16.00]

10.48 [5.80,15.16]

P-value Between groups

0.009

0.007

0.003

0.04

  1. GMFM-66 Gross motor function measure-66, T1 One-month data collection, T2 Three-month data collection, T3 Six-month data collection, T4 One-year data collection
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us